Taken together, these results indicate that the VDAC1 depletion-mediated effects on GBM tumors involve alterations in the expression of about 5000 genes including those associated with re-programed metabolism and modifying the epigenetic landscape. The gene discussed is VDAC1; the disease is glioblastoma.